483 results on '"Turajlic, Samra"'
Search Results
2. Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment
3. Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma
4. Interpretability of radiomics models is improved when using feature group selection strategies for predicting molecular and clinical targets in clear-cell renal cell carcinoma: insights from the TRACERx Renal study
5. Interferon signaling promotes tolerance to chromosomal instability during metastatic evolution in renal cancer
6. Nilotinib in KIT-driven advanced melanoma: Results from the phase II single-arm NICAM trial
7. Antibodies against endogenous retroviruses promote lung cancer immunotherapy
8. Optimisation of b-values for the accurate estimation of the apparent diffusion coefficient (ADC) in whole-body diffusion-weighted MRI in patients with metastatic melanoma
9. Pervasive chromosomal instability and karyotype order in tumour evolution
10. The road to systemic therapy in von Hippel-Lindau (VHL) disease: Are we there yet?
11. Hereditary Renal Cancer Predisposition Syndromes
12. The status of tumor mutational burden and immunotherapy
13. COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety
14. The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs—Part B: Prostate and Urinary Tract Tumors
15. The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours
16. Predicting cancer evolution for patient benefit: Renal cell carcinoma paradigm
17. The spectrum of cardiovascular complications related to immune-checkpoint inhibitor treatment: Including myocarditis and the new entity of non inflammatory left ventricular dysfunction
18. Spatial patterns of tumour growth impact clonal diversification in a computational model and the TRACERx Renal study
19. Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study
20. Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study
21. Evolution of Renal Cell Carcinoma
22. British Society of Gastroenterology endorsed guidance for the management of immune checkpoint inhibitor-induced enterocolitis
23. Five-year review of corticosteroid duration and complications in the management of immune checkpoint inhibitor-related diarrhoea and colitis in advanced melanoma
24. How we treat neurological toxicity from immune checkpoint inhibitors
25. Abstract A007: Representative sampling of invasive breast carcinomas: Interim report from a prospective study (HOLST-F)
26. Abstract PR015: Interpretable computational pathology reveals that vascular networks reflect evolutionary dynamics in kidney cancer
27. Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma
28. Increased incidence of co-trimoxazole-induced rash in patients on systemic corticosteroid treatment for toxicity associated with immune checkpoint inhibitors.
29. Tumour mutational burden: primary versus metastatic tissue creates systematic bias
30. Why I pivoted from COVID-19 back to cancer research
31. An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors
32. Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium
33. 1312 Identification and validation of immunogenic clonal neoantigens for personalized therapies
34. Whole-genome sequencing uncovers the genomic determinants of therapeutic resistance to immune checkpoint blockade
35. Contemporary outcomes from the use of regular imaging to detect relapse in high-risk cutaneous melanoma
36. Resolving genetic heterogeneity in cancer
37. Therapeutic inhibition of monocyte recruitment prevents checkpoint inhibitor-induced hepatitis
38. Abstract IA025: The cell of origin is the dominant constraint in evolution of VHL related neoplasms
39. Independent SARS-CoV-2 staff testing protected academic and health-care institutions in northwest London
40. Saturation Genome Editing Resolves the Functional Spectrum of PathogenicVHLAlleles
41. Escape from nonsense-mediated decay associates with anti-tumor immunogenicity
42. Data from Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways
43. Supplementary Tables S1-S8 from Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways
44. Supplementary Figures S1-S25 from Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways
45. Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer
46. Abstract 6794: SETD2 loss in renal cell carcinoma generates peptides from aberrantly translated retained introns
47. Abstract 5709: Whole genome error-corrected sequencing for sensitive circulating tumor DNA cancer monitoring
48. Supplementary Table S4 from Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in Melanoma
49. Data from Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in Melanoma
50. Supplementary Figures S1-S7 from SF3B1 Mutations Are Associated with Alternative Splicing in Uveal Melanoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.